NanoMedical Systems Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
2ndary - Private
- Investors
-
14
NanoMedical Systems General Information
Description
Developer of a personalized molecular drug delivery system designed to address unmet clinical needs for personalized medicine. The company's system uses a molecule-sized nanochannel chip, that isolates the peptides and small proteins in a single drop of fluid to deliver a biomarker-enriched sample for diagnostic analysis, enabling doctors and physicians to provide improved safety treatment to patients and innovative nanotechnology-based medical services.
Contact Information
Website
www.nanomedsys.comCorporate Office
- HighFlex Technology Center
- 12708 Riata Vista Circle, Suite A-105
- Austin, TX 78727
- United States
Corporate Office
- HighFlex Technology Center
- 12708 Riata Vista Circle, Suite A-105
- Austin, TX 78727
- United States
NanoMedical Systems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 01-May-2023 | Completed | Generating Revenue | |||
| 7. Grant | 31-Dec-2018 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 25-May-2018 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series 2) | 09-May-2017 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 02-Mar-2016 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 19-Dec-2013 | Completed | Generating Revenue | |||
| 2. Grant | 27-Dec-2009 | $3.5M | $4.2M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 18-Dec-2007 | $4.2M | $4.2M | Completed | Startup |
NanoMedical Systems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series 2B | ||||||||
| Series 2A | ||||||||
| Series 1 | 1,400,000 | $0.001000 | $7.37 | $7.37 | 1x | $7.37 | 12.06% |
NanoMedical Systems Comparisons
Industry
Financing
Details
NanoMedical Systems Competitors (27)
One of NanoMedical Systems’s 27 competitors is CytImmune Sciences, a Private Equity-Backed company based in Rockville, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytImmune Sciences | Private Equity-Backed | Rockville, MD | ||||
| PharmaIN | Venture Capital-Backed | Bothell, WA | ||||
| Centrose | Venture Capital-Backed | Middleton, WI | ||||
| Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands | ||||
| CRISPR Therapeutics | Formerly VC-backed | Zug, Switzerland |
NanoMedical Systems Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NanoMedical Systems Patents
NanoMedical Systems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200173966-A1 | Devices and methods for enriching peptides during bioanalytical sample preparation | Inactive | 01-Jun-2017 | ||
| EP-3631438-A4 | Devices and methods for enriching peptides during bioanalytical sample preparation | Inactive | 01-Jun-2017 | ||
| EP-3631438-A2 | Devices and methods for enriching peptides during bioanalytical sample preparation | Inactive | 01-Jun-2017 | ||
| US-20160310625-A1 | Device and method for sustained release of fragrant compound | Inactive | 10-Dec-2013 | ||
| EP-3033138-A1 | Device and method for sustained release of low water solubility therapeutic agent in solubilizer | Inactive | 12-Aug-2013 | A61M31/002 |
NanoMedical Systems Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NanoMedical Systems Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| United States Department of Defense | Government | |||
| Amos Ben-Meir | Angel (individual) | Minority | ||
| Everest Pinnacle Capital | Venture Capital | Minority | ||
| InterFinancial Holdings | Corporation | Minority | ||
| Kevin Doner | Angel (individual) | Minority |
NanoMedical Systems FAQs
-
When was NanoMedical Systems founded?
NanoMedical Systems was founded in 2006.
-
Where is NanoMedical Systems headquartered?
NanoMedical Systems is headquartered in Austin, TX.
-
What is the size of NanoMedical Systems?
NanoMedical Systems has 7 total employees.
-
What industry is NanoMedical Systems in?
NanoMedical Systems’s primary industry is Drug Delivery.
-
Is NanoMedical Systems a private or public company?
NanoMedical Systems is a Private company.
-
What is NanoMedical Systems’s current revenue?
The current revenue for NanoMedical Systems is .
-
How much funding has NanoMedical Systems raised over time?
NanoMedical Systems has raised $11.4M.
-
Who are NanoMedical Systems’s investors?
United States Department of Defense, Amos Ben-Meir, Everest Pinnacle Capital, InterFinancial Holdings, and Kevin Doner are 5 of 14 investors who have invested in NanoMedical Systems.
-
Who are NanoMedical Systems’s competitors?
CytImmune Sciences, PharmaIN, Centrose, Cristal Therapeutics, and CRISPR Therapeutics are some of the 27 competitors of NanoMedical Systems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
